Last reviewed · How we verify
NCT07120841: Nurse-TEL-CVD
Nurse Telephone Follow-up for Cardiovascular Patients
NA trial testing Telephone Education in Depression, Anxiety Disorders in 60 participants. Completed in 21 December 2023.
21 December 2023
Quick facts
| Lead sponsor | Mazandaran University of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 23 November 2023 |
| Primary completion | 21 December 2023 |
| Estimated completion | 21 December 2023 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Telephone Education
- Standard Care (in control arm) — full drug profile →
Conditions studied
- Depression, Anxiety Disorders — all drugs for Depression, Anxiety Disorders →
- Follow-up Study — all drugs for Follow-up Study →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Mazandaran University of Medical Sciences
Who can join
18 and older, any sex, with Depression, Anxiety Disorders or Follow-up Study. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of follow-up telephone education provided by a nurse on the levels of anxiety, stress, and depression in patients hospitalized in the cardiac intensive care unit during the two weeks after discharge. Patients will be randomly assigned to either the intervention (education) group or the control group. Their levels of anxiety, stress, and depression will be measured before and after the intervention. The aim is to determine whether this educational intervention can improve the psychological well-being of these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07120841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mazandaran University of Medical Sciences trials
Trials by the same sponsor.
- NCT06737406 — Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart · NA · recruiting
- NCT06812000 — Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy · completed
- NCT06653348 — Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke · Phase 2, PHASE3 · recruiting
- NCT07210450 — Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia · Phase 2, PHASE3 · completed
- NCT05969730 — Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07120841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mazandaran University of Medical Sciences
- Last refreshed: 13 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07120841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing